Avastin (bevacizumab)

pCPA File Number: 20921
Negotiation Status:
Concluded with an LOI
Indication(s):
Platinum-Resistant Ovarian Cancer
Sponsor/Manufacturer:
Hoffmann-La Roche Ltd.
CDA-AMC Project Number:
PC0066-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: